The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.
Clinically isolated syndromes
MRI
disease-modifying treatment
multiple sclerosis
prediction
prognosis
Journal
Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
pubmed:
16
10
2019
medline:
25
9
2021
entrez:
16
10
2019
Statut:
ppublish
Résumé
To explore the long-term outcomes of patients with clinically isolated syndromes from the Barcelona cohort. We selected patients with a follow-up longer than 10 years to (1) estimate the risks of multiple sclerosis (MS) and disability accumulation according to the baseline number of T2 lesions and to compare treated versus untreated patients and early versus delayed treatment, and (2) to study baseline features of patients with aggressive MS (Expanded Disability Status Scale (EDSS) ⩾6.0 at 10 years). In all, 401 patients were included (mean follow-up of 14.4 (standard deviation of 2.9) years). A higher number of T2 lesions was associated with an earlier MS diagnosis and an earlier risk of irreversible disability. Early treatment was associated with a decreased risk of EDSS of 3.0: adjusted hazard ratio = 0.4, 95% confidence interval = (0.2, 0.7). Patients with aggressive MS differed in their baseline brain magnetic resonance images: The median (interquartile range) number of T2 lesions and contrast-enhancing lesions (CEL) was 71 (28-95) versus 7 (1-19) and 3 (1-24) versus 0 (0-1), respectively. The cut-offs that better classified patients with aggressive MS were 20 for T2 lesions and 2 for CEL. Although MS natural history is changing, a high lesion load at onset is helpful to identify patients at risk of presenting an aggressive MS.
Identifiants
pubmed: 31610739
doi: 10.1177/1352458519877810
pmc: PMC7604549
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1658-1669Références
Neurology. 2004 Jan 13;62(1):51-9
pubmed: 14718697
Ann Neurol. 2005 Dec;58(6):840-6
pubmed: 16283615
Neurology. 2016 Sep 6;87(10):978-87
pubmed: 27511182
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
N Engl J Med. 2002 Jan 17;346(3):158-64
pubmed: 11796849
Brain. 1998 Mar;121 ( Pt 3):495-503
pubmed: 9549525
Ann Neurol. 2016 Jul;80(1):89-100
pubmed: 27145331
Nat Rev Neurol. 2015 Jul;11(7):379-89
pubmed: 26032396
Brain. 2008 Mar;131(Pt 3):808-17
pubmed: 18234696
Ann Clin Transl Neurol. 2015 May;2(5):479-91
pubmed: 26000321
Ann Neurol. 1983 Mar;13(3):227-31
pubmed: 6847134
Neurology. 2006 Jan 24;66(2):172-7
pubmed: 16434648
N Engl J Med. 2000 Nov 16;343(20):1430-8
pubmed: 11078767
Ann Neurol. 2016 Oct;80(4):499-510
pubmed: 27464262
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Brain. 1989 Feb;112 ( Pt 1):133-46
pubmed: 2917275
Nat Rev Neurol. 2017 Feb;13(2):105-118
pubmed: 28084327
J Neurol. 2015 May;262(5):1148-63
pubmed: 25712541
Brain. 2015 Jul;138(Pt 7):1863-74
pubmed: 25902415
Arch Neurol. 2005 Jun;62(6):865-70
pubmed: 15956157